BE379821A - - Google Patents
Info
- Publication number
- BE379821A BE379821A BE379821DA BE379821A BE 379821 A BE379821 A BE 379821A BE 379821D A BE379821D A BE 379821DA BE 379821 A BE379821 A BE 379821A
- Authority
- BE
- Belgium
- Prior art keywords
- iodemethanesulfonic
- salts
- acid
- emi
- solutions
- Prior art date
Links
- 239000002253 acid Substances 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 18
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- 125000002723 alicyclic group Chemical group 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 3
- 210000001635 urinary tract Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004197 pelvis Anatomy 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE647244T | 1930-06-10 | ||
| DE654705T | 1930-07-08 | ||
| DE652594T | 1930-07-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE379821A true BE379821A (enrdf_load_stackoverflow) |
Family
ID=31498890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE379821D BE379821A (enrdf_load_stackoverflow) | 1930-06-10 |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE379821A (enrdf_load_stackoverflow) |
| DK (1) | DK48137C (enrdf_load_stackoverflow) |
| FR (1) | FR718438A (enrdf_load_stackoverflow) |
| NL (1) | NL33580C (enrdf_load_stackoverflow) |
-
0
- BE BE379821D patent/BE379821A/fr unknown
-
1931
- 1931-06-09 FR FR718438D patent/FR718438A/fr not_active Expired
- 1931-06-30 DK DK48137D patent/DK48137C/da active
- 1931-07-03 NL NL57534A patent/NL33580C/xx active
Also Published As
| Publication number | Publication date |
|---|---|
| DK48137C (da) | 1933-12-11 |
| FR718438A (fr) | 1932-01-25 |
| NL33580C (enrdf_load_stackoverflow) | 1934-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2820814A (en) | Polyiodinated 5-aminoisophthalic acids, salts, and esters | |
| Mao et al. | Usefulness of contrast‐enhanced ultrasound in the diagnosis of biliary leakage following T‐tube removal | |
| JPS5869810A (ja) | 改良された腹腰透析溶液 | |
| BE379821A (enrdf_load_stackoverflow) | ||
| WO1993005782A1 (fr) | Sels de sparfloxacine et solutions les contenant | |
| BLACKFAN et al. | Acute glomerular nephritis in children: treatment of the cerebral manifestations | |
| JPH05505813A (ja) | ４―［２―（ベンゼンスルホニルアミノ）―エチル］―フェノキシ酢酸の医薬用水溶液 | |
| RU2110281C1 (ru) | Заменитель плазмы крови | |
| US3062719A (en) | Trisodium calcium diethylenetriaminepentaacetic acid, compositions containing the same, and the use thereof | |
| Sapeika | Lead EDTA complex-a water-soluble contrast medium | |
| Heathcote et al. | Per-Abrodil (Pelviren D): an experimental investigation | |
| Finby et al. | Ninety per cent Hypaque for rapid intravenous roentgenography: preliminary report | |
| Harbaugh | Dissolution of renal calculus with allopurinol: a case report | |
| US2894023A (en) | Salts of the tri-ethyl ester of n-hydroxyethyl ethylene diamine triacetic acid | |
| Gardner et al. | An experimental investigation of Uroselectan B | |
| Katz et al. | The hemodynamic effect of the dioxane derivative 933 F on trained unanesthetized normal and renal hypertensive dogs and its effect on the pressor action of renin | |
| Schick et al. | Fuadin therapy of schistosomiasis associated with ventricular tachycardia and death: a case report | |
| SU1395251A1 (ru) | Способ консервации трупа | |
| Kaufman | Experiences with Thixokon: an aqueous, thixotropic urethrographic medium | |
| US1868602A (en) | Contrast media for x-ray photography | |
| US2143324A (en) | Diuretic composition | |
| Olin | Precipitation of a Cholegraphic Contrast Medium in a Dog | |
| DE652594C (de) | Roentgenologisches Verfahren | |
| Küpeli et al. | Vas deferens calculus | |
| Bowers | Butazolidin |